Genetic variants of the MBL2 gene are associated with mortality in pneumococcal sepsis

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 1, 2012, Pages 39-44

  Garnacho Montero, José ^a   García Cabrera, Emilio ^a   Jiménez Álvarez, Rocio ^a   Díaz Martín, Ana ^a   Revuelto Rey, Jaume ^a   Aznar Martín, Javier ^a   Garnacho Montero, Carmen ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Mortality; Single nucleotide polymorphisms; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; FC RECEPTOR IIA; LEVOFLOXACIN; MANNOSE BINDING LECTIN 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL GENE; BACTERIAL MENINGITIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; FC GAMMA IIA GENE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAZARD RATIO; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MBL2 GENE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS PNEUMONIAE; TLR2 GENE; TLR4 GENE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; MUTATION; PNEUMOCOCCAL INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; SEPSIS; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84860712929     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.02.002     Document Type: Article

References (45)

1. Armstrong L., Medford A.R., Hunter K.J., Uppington K.M., Millar A.B. Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 2004, 136(2):312-319.
2. Berjohn C.M., Fishman N.O., Joffe M.M., Edelstein P.H., Metlay J.P. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia. Medicine (Baltimore) 2008, 87(3):160-166.
3. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101(6):1644-1655.
4. Brouwer M.C., de Gans J., Heckenberg S.G., Zwinderman A.H., van der Poll T., van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2009, 9(1):31-44.
5. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
6. Clinical and Laboratory Standard Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 19th information supplement 2009, CLSI, Wayne, PA.
7. Crosdale D.J., Ollier W.E., Thomson W., Dyer P.A., Jensenious J., Johnson R.W., et al. Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur J Immunogenet 2000, 27(3):111-117.
8. Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra T., Cohen J., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30(4):536-555.
9. Eisen D.P., Dean M.M., Boermeester M.A., Fidler K.J., Gordon A.C., Kronborg G., et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 2008, 47(4):510-516.
10. Endeman H., Cornips M.C., Grutters J.C., van den Bosch J.M., Ruven H.J., van Velzen-Blad H., et al. The Fcgamma receptor IIA-R/R131 genotype is associated with severe sepsis in community-acquired pneumonia. Clin Vaccine Immunol 2009, 16(7):1087-1090.
11. Endeman H., Herpers B.L., de Jong B.A., Voorn G.P., Grutters J.C., van Velzen-Blad H., et al. Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia. Chest 2008, 134(6):1135-1140.
12. Garau J., Aguilar L., Rodríguez-Créixems M., Dal-ré R., Pérez-Trallero E., Rodríguez M., et al. Influence of comorbidity and severity on the clinical outcome of bacteremic pneumococcal pneumonia treated with beta-lactam monotherapy. J Chemother 1999, 11(4):266-272.
13. Garcia-Laorden M.I., Sole-Violan J., Rodriguez de Castro F., Aspa J., Briones M.L., Garcia-Saavedra A., et al. Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J Allergy Clin Immunol 2008, 122(2):368-374. 374.e1-2.
14. Garcia-Vidal C., Ardanuy C., Tubau F., Viasus D., Dorca J., Liñares J., et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax 2010, 65(1):77-81.
15. Garnacho-Montero J., García-Cabrera E., Diaz-Martín A., Lepe-Jiménez J.A., Iraurgi-Arcarazo P., Jiménez-Alvarez R., et al. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment. Scand J Infect Dis 2010, 42(3):185-192.
16. Garnacho-Montero J., Garcia-Garmendia J.L., Barrero-Almodovar A., Jimenez-Jimenez F.J., Perez-Paredes C., Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003, 31(12):2742-2751.
17. Garred P., J Strøm J., Quist L., Taaning E., Madsen H.O. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003, 188(9):1394-1403.
18. Gordon A.C., Waheed U., Hansen T.K., Hitman G.A., Garrard C.S., Turner M.W., et al. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock 2006, 25(1):88-93.
19. Hausdorff W.P., Feikin D.R., Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005, 5(2):83-93.
20. Hessner M.J., Curtis B.R., Endean D.J., Aster R.H. Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers. Transfusion 1996, 36(10):895-899.
21. Huh J.W., Song K., Yum J.S., Hong S.B., Lim C.M., Koh Y. Association of mannose-binding lectin-2 genotype and serum levels with prognosis of sepsis. Crit Care 2009, 13(6):R176.
22. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13(10):818-829.
23. Kronborg G., Weis N., Madsen H.O., Pedersen S.S., Wejse C., Nielsen H., et al. Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J Infect Dis 2002, 185(10):1517-1520.
24. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31(4):1250-1256.
25. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., Schwartz D.A. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000, 68(11):6398-6401.
26. Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002, 162(9):1028-1032.
27. Lynch J.P., Zhanel G.G. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009, 30(2):189-209.
28. Madsen H.O., Satz M.L., Hogh B., Svejgaard A., Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998, 161(6):3169-3175.
29. Moens L., Verhaegen J., Pierik M., Vermeire S., De Boeck K., Peetermans W.E., et al. Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease. Microbes Infect 2007, 9(1):15-20.
30. Moroney J.F., Fiore A.E., Harrison L.H., Patterson J.E., Farley M.M., Jorgensen J.H., et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001, 33(6):797-805.
31. Myles P.R., Hubbard R.B., Gibson J.E., Pogson Z., Smith C.J., McKeever T.M. Pneumonia mortality in a UK general practice population cohort. Eur J Public Health 2009, 19(5):521-526.
32. Pai R., Gertz R.E., Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 2006, 44(1):124-131.
33. Perez-Castellano M., Peñaranda M., Payeras A., Milà J., Riera M., Vidal J., et al. Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia. Clin Exp Immunol 2006, 145(2):228-234.
34. Pittet D., Thiévent B., Wenzel R.P., Li N., Gurman G., Suter P.M. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993, 19(5):265-272.
35. Roed C., Engsig F.N., Omland L.H., Skinhoj P., Obel N. Long-term mortality in patients diagnosed with pneumococcal meningitis: a Danish nationwide cohort study. Am J Epidemiol 2010, 172(3):309-317.
36. Sanders L.A., van de Winkel J.G., Rijkers G.T., Voorhorst-Ogink M.M., de Haas M., Capel P.J., et al. Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 1994, 170(4):854-861.
37. Schaaf B.M., Boehmke F., Esnaashari H., Seitzer U., Kothe H., Maass M., et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 2003, 168(4):476-480.
38. Solé-Violán J., García-Laorden M.I., Marcos-Ramos J.A., de Castro F.R., Rajas O., Borderías L., et al. The Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia. Crit Care Med 2011, 39(6):1388-1393.
39. Summerfield J.A. Clinical potential of mannose-binding lectin-replacement therapy. Biochem Soc Trans 2003, 31(Pt 4):770-773.
40. Sutherland A.M., Walley K.R., Russell J.A. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 2005, 33(3):638-644.
41. Vallès X., Roca A., Lozano F., Morais L., Suárez B., Casals F., et al. Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency. Eur Respir J 2010, 36(4):856-863.
42. van der Poll T., Opal S.M. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008, 8(1):32-43.
43. Watanakunakorn C., Bailey T.A. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases. Arch Intern Med 1997, 157(17):1965-1971.
44. Yee A.M., Phan H.M., Zuniga R., Salmon J.E., Musher D.M. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis 2000, 30(1):25-28.
45. Yende S., Angus D.C. Long-term outcomes from sepsis. Curr Infect Dis Rep 2007, 9(5):382-386.